Clotting vs. bleeding : the importance of pharmacologic thromboprophylaxis in IBD
No Thumbnail Available
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Abstract
Abstract
"Inflammatory bowel disease (IBD) patients are at increased risk of developing venous thromboembolism (VTE), a complication associated with significant morbidity and mortality. Despite this, pharmacologic prophylaxis (with heparin products) is still under implemented owing to both a lack of awareness of the degree of thrombotic risk and concerns over adverse events (bleeding). The following case serves to illustrate the importance of initiating pharmacologic VTE prophylaxis in a patient with active bleeding in the setting of IBD."--Introduction
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.